MAOA inhibits the metastasis of hepatocellular carcinoma cells by suppressing the adrenergic system and activating the epidermal growth factor receptor (EGFR) signaling pathway, showing a negative correlation with hepatocellular carcinoma progression (Li et al., 2014). The gene discussed is MAOA; the disease is hepatocellular carcinoma.